2m 2m 2m 2m 2m 2m 2m
EVOLUS (EOLS)
NASDAQ
$7.14-$0.56 (-7.22%)
Price as of Oct 02, 2026 5:37 PM EDT- $507.9MMarket Cap
- 23.24%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
EVOLUS (EOLS)
$7.14-$0.56 (-7.22%)
EOLS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.69 | ||
Change | -$0.31 (-3.87%) | ||
Open | $7.89 | ||
High | $8.01 | ||
Low | $7.69 | ||
Previous Close | $8.00 | ||
Volume | 922,569 | ||
30-Day Average Volume | 731,947 | ||
1-Week Change | -2.16% | ||
1-Month Change | -15.31% | ||
1-Year Change | 23.24% | ||
3-Year Change | -15.86% | ||
5-Year Change | -0.52% | ||
Fundamentals | |||
Shares Outstanding | 66.1M | ||
Total Assets | $248.0M | ||
Market Cap | $507.9M | ||
Enterprise Value | $619.5M | ||
Period: QTR TTM FY | |||
Revenue | $83.3M | ||
Net Income | -$8.1M | ||
Free Cash Flow | -$3.6M | ||
EBIT | -$8.2M | ||
EBITDA | -$5.9M | ||
Net Working Capital | $68.8M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -106 | ||
Enterprise Value/Revenue | 7 | ||
P/B | -16 | ||
P/E | -64 | ||
PEG | -3 | ||
Price/Free Cash Flow | -140 | ||
Price/Operating Cash Flow | -142 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue